52492 Federal Register / Vol. 74, No. 196 / Tuesday, October 13, 2009 / Notices 

that strive to augment the informed 

consent document and increase a 

subject’s understanding of research 

participation. The meeting will 

conclude with a panel of speakers 

focusing on the regulatory barriers that 

may be associated with Community 

Based and Participatory Research. 

Public comment will be heard on both 

days. 

Public attendance at the meeting is 

limited to space available. Individuals 

who plan to attend the meeting and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the designated contact persons. 

Members of the public will have the 

opportunity to provide comments on 

both days of the meeting. Public 

comment will be limited to five minutes 

per speaker. Any members of the public 

who wish to have printed materials 

distributed to SACHRP members for this 

scheduled meeting should submit 

materials to the Executive Director, 

SACHRP, prior to the close of business 

Thursday, October 22, 2009. 

Information about SACHRP and the 

draft meeting agenda will be posted on 

the SACHRP Web site at: http:// 

www.hhs.gov/ohrp/sachrp/index.html. 

Dated: October 6, 2009. 

Jerry Menikoff, 

Director, Office for Human Research 

Protections, Executive Secretary, Secretary’s 

Advisory Committee on Human Research 

Protections. 

[FR Doc. E9–24482 Filed 10–9–09; 8:45 am] 

BILLING CODE 4150–36–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Advisory Committee on 

Blood Safety and Availability 

AGENCY: Department of Health and 

Human Services, Office of the Secretary. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the U.S. 

Department of Health and Human 

Services is hereby giving notice that the 

Advisory Committee on Blood Safety 

and Availability (ACBSA) will hold a 

meeting. The meeting will be open to 

the public. 

DATES: The meeting will take place 

Thursday, November 19 and Friday, 

November 20, 2009 from 8:30 a.m. to 5 

p.m. 

ADDRESSES: The Universities at Shady 

Grove, 9630 Gudelsky Drive, Rockville, 

MD 20850, Phone: 301–738–6000. 

FOR FURTHER INFORMATION CONTACT: Jerry 

A. Holmberg, PhD, Executive Secretary, 

Advisory Committee on Blood Safety 

and Availability, Office of Public Health 

and Science, Department of Health and 

Human Services, 1101 Wootton 

Parkway, Suite 250, Rockville, MD 

20852, (240) 453–8803, FAX (240) 453– 

8456, e-mail ACBSA@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Advisory Committee on Blood Safety 

and Availability provides advice to the 

Secretary and the Assistant Secretary for 

Health on a range of policy issues that 

impact (1) Definition of public health 

parameters around safety and 

availability of the blood supply and 

blood products, (2) broad public health, 

ethical and legal issues related to 

transfusion and transplantation safety, 

and (3) the implications for safety and 

the availability of various economic 

factors affecting product cost and 

supply. 

In keeping with its established 

mission, the ACBSA has been asked to 

review and comment on the current 

processes and parameters which should 

be used in the decision-making process 

for transplantation safety policy. At the 

November 19 and 20, 2009 meeting, the 

Committee will be asked to comment 

and make recommendations on current 

safety decision making processes within 

the Department of Health and Human 

Services while considering those same 

processes within the Private Sector. 

During the meeting, the ACBSA will 

be provided a briefing on Biovigilance 

(surveillance of blood, organs, and 

tissues safety). Specifically, the 

committee will be asked to comment on 

the white paper entitled, ‘‘Biovigilance 

in the United States: Efforts to Bridge a 

Critical Gap in Patient Safety and Donor 

Health.’’ 

The public will have opportunity to 

present their views to the Committee on 

both meeting days. A public comment 

session has been scheduled for 

November 19 and 20, 2009. Comments 

will be limited to five minutes per 

speaker and must be pertinent to the 

discussion. Pre-registration is required 

for participation in the public comment 

session. Any member of the public who 

would like to participate in this session 

is encouraged to contact the Executive 

Secretary at his/her earliest 

convenience. It is requested that those 

who wish to have printed material 

distributed to the Committee provide 

thirty (30) copies of the document to be 

distributed to the Executive Secretary, 

ACBSA, prior to close of business 

November 16, 2009. If it is not possible 

to provide 30 copies of the material to 

be distributed, then individuals are 

requested to provide at a minimum one 

(1) copy of the document(s) to be 

distributed prior to the close of business 

November 16, 2009. It also is requested 

that any member of the public who 

wishes to provide comments to the 

Committee utilizing electronic data 

projection submit the necessary material 

to the Executive Secretary prior to close 

of business November 16, 2009. 

Dated: September 25, 2009. 

Jerry A. Holmberg, 

Executive Secretary, Advisory Committee on 

Blood Safety and Availability. 

[FR Doc. E9–24483 Filed 10–9–09; 8:45 am] 

BILLING CODE 4150–41–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–10–0612] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Maryam Daneshvar, 

CDC Acting Reports Clearance Officer, 

1600 Clifton Road, MS–D74, Atlanta, 

GA 30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Well-Integrated Screening and 

Evaluation for Women Across the 

Nation (WISEWOMAN) Reporting 

System (OMB #0920–0612, exp. 

1/31/2010)—Revision—National Center 


erowe on DSK5CLS3C1PROD with NOTICES